Back
Innate Pharma SA Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
58
IPHA
Innate Pharma SA
Last Price:
$2.25
Seasonality Move:
-9.96%
Sell
36
CRSP
CRISPR Therapeutics AG
Last Price:
$36.59
Seasonality Move:
22.33%
Buy
58
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.32. The Score for IPHA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
IPHA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.59. The Score for CRSP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.32The current trend is moderately bullish and IPHA is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 62.69 | Buy |
Chaikin Money Flow: | -7694 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.85 - 2.27) | Buy |
Bollinger Bands (100): | (1.78 - 2.2) | Buy |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.85 | Buy |
Relative Strength Index (14 RSI): | 50.97 | Buy |
Chaikin Money Flow: | 1002793 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.67 - 39.15) | Buy |
Bollinger Bands (100): | (36.56 - 44.44) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Buy |
20-day SMA: | 2.13 | Buy |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2.01 | Buy |
8-day EMA: | 2.3 | Buy |
20-day EMA: | 2.18 | Buy |
50-day EMA: | 2.06 | Buy |
200-day EMA: | 2.07 | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.3 | Buy |
20-day SMA: | 37.53 | Buy |
50-day SMA: | 38.55 | Sell |
200-day SMA: | 44.73 | Sell |
8-day EMA: | 36.45 | Buy |
20-day EMA: | 35.9 | Buy |
50-day EMA: | 28.51 | Buy |
200-day EMA: | 11.44 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.
Innate Pharma SA Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |